{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:32:38Z","timestamp":1777599158592,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81803609"],"award-info":[{"award-number":["81803609"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22077110"],"award-info":[{"award-number":["22077110"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22377103"],"award-info":[{"award-number":["22377103"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010023","name":"Natural Science Research of Jiangsu Higher Education Institutions of China","doi-asserted-by":"publisher","award":["20KJA350001"],"award-info":[{"award-number":["20KJA350001"]}],"id":[{"id":"10.13039\/501100010023","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Jiangsu Province Natural Science Foundation","doi-asserted-by":"publisher","award":["BK20200106"],"award-info":[{"award-number":["BK20200106"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.bcp.2024.116200","type":"journal-article","created":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T22:03:12Z","timestamp":1712700192000},"page":"116200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Notch3 as a novel therapeutic target for the treatment of ADPKD by regulating cell proliferation and renal cyst development"],"prefix":"10.1016","volume":"224","author":[{"given":"Limin","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongtao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zifan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiande","family":"Luan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kequan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6142-4825","authenticated-orcid":false,"given":"Dong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2024.116200_b0005","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev.med.60.101707.125712","article-title":"Polycystic kidney disease","volume":"60","author":"Harris","year":"2009","journal-title":"Annu. Rev. Med."},{"issue":"14","key":"10.1016\/j.bcp.2024.116200_b0010","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMcp0804458","article-title":"Clinical practice. Autosomal dominant polycystic kidney disease","volume":"359","author":"Grantham","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"9147","key":"10.1016\/j.bcp.2024.116200_b0015","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0140-6736(98)03495-3","article-title":"Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group","volume":"353","author":"Hateboer","year":"1999","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bcp.2024.116200_b0020","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/ndt\/gfy297","article-title":"Pro: Tolvaptan delays the progression of autosomal dominant polycystic kidney disease","volume":"34","author":"Torres","year":"2019","journal-title":"Nephrol. Dial. Transplant."},{"issue":"1","key":"10.1016\/j.bcp.2024.116200_b0025","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s12882-017-0686-3","article-title":"Effect of tolvaptan on renal handling of water and sodium, GFR and central hemodynamics in autosomal dominant polycystic kidney disease during inhibition of the nitric oxide system: a randomized, placebo-controlled, double blind, crossover study","volume":"18","author":"Al","year":"2017","journal-title":"BMC Nephrol."},{"issue":"10","key":"10.1016\/j.bcp.2024.116200_b0030","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1681\/ASN.2018060590","article-title":"A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan","volume":"29","author":"Chebib","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.bcp.2024.116200_b0035","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ydbio.2009.11.017","article-title":"The contribution of Notch1 to nephron segmentation in the developing kidney is revealed in a sensitized Notch2 background and can be augmented by reducing Mintdosage","volume":"337","author":"Surendran","year":"2010","journal-title":"Dev. Biol."},{"issue":"2","key":"10.1016\/j.bcp.2024.116200_b0040","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/path.2967","article-title":"Notch in the kidney: development and disease","volume":"226","author":"Sirin","year":"2012","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116200_b0045","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00041552-200301000-00002","article-title":"Notch signaling in kidney development","volume":"12","author":"McCright","year":"2003","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"2","key":"10.1016\/j.bcp.2024.116200_b0050","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cell.2009.03.045","article-title":"The canonical Notch signaling pathway: unfolding the activation mechanism","volume":"137","author":"Kopan","year":"2009","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.bcp.2024.116200_b0055","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nrm2009","article-title":"Notch signalling: a simple pathway becomes complex","volume":"7","author":"Bray","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116200_b0060","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/jcmm.13926","article-title":"Gamma-secretase inhibitor DAPT mitigates cisplatin-induced acute kidney injury by suppressing Notch1 signaling","volume":"23","author":"Soni","year":"2019","journal-title":"J. Cell Mol. Med."},{"issue":"11","key":"10.1016\/j.bcp.2024.116200_b0065","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/ki.2008.74","article-title":"Expression and function of the Delta-1\/Notch-2\/Hes-1 pathway during experimental acute kidney injury","volume":"73","author":"Kobayashi","year":"2008","journal-title":"Kidney Int."},{"issue":"11","key":"10.1016\/j.bcp.2024.116200_b0070","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1172\/JCI43025","article-title":"Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans","volume":"120","author":"Bielesz","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bcp.2024.116200_b0075","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/MNH.0b013e3283414c88","article-title":"The story of Notch and chronic kidney disease","volume":"20","author":"Sharma","year":"2011","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"1","key":"10.1016\/j.bcp.2024.116200_b0080","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1038\/s41598-018-21132-3","article-title":"Aberrant Regulation of Notch3 Signaling Pathway in Polycystic Kidney Disease","volume":"8","author":"Idowu","year":"2018","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.bcp.2024.116200_b0085","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s42255-020-0227-4","article-title":"Super-enhancer-driven metabolic reprogramming promotes cystogenesis in autosomal dominant polycystic kidney disease","volume":"2","author":"Mi","year":"2020","journal-title":"Nat Metab"},{"issue":"13","key":"10.1016\/j.bcp.2024.116200_b0090","doi-asserted-by":"crossref","first-page":"9295","DOI":"10.1021\/acs.jmedchem.2c00567","article-title":"Benzodiazepine Derivatives as Potent Vasopressin V(2) Receptor Antagonists for the Treatment of Autosomal Dominant Kidney Disease","volume":"65","author":"Cao","year":"2022","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bcp.2024.116200_b0095","doi-asserted-by":"crossref","first-page":"7717","DOI":"10.1021\/acs.jmedchem.2c00011","article-title":"Long Residence Time at the Vasopressin V(2) Receptor Translates into Superior Inhibitory Effects in Ex Vivo and In Vivo Models of Autosomal Dominant Polycystic Kidney Disease","volume":"65","author":"Zhang","year":"2022","journal-title":"J. Med. Chem."},{"issue":"16","key":"10.1016\/j.bcp.2024.116200_b0100","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.7150\/thno.19989","article-title":"Notch3 Maintains Luminal Phenotype and Suppresses Tumorigenesis and Metastasis of Breast Cancer via Trans-Activating Estrogen Receptor-alpha","volume":"7","author":"Dou","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.bcp.2024.116200_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114675","article-title":"Sarsasapogenin restores podocyte autophagy in diabetic nephropathy by targeting GSK3beta signaling pathway","volume":"192","author":"Li","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"11","key":"10.1016\/j.bcp.2024.116200_b0110","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/hmg\/ddn039","article-title":"Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1","volume":"17","author":"Shibazaki","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bcp.2024.116200_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104751","article-title":"Cardamonin retards progression of autosomal dominant polycystic kidney disease via inhibiting renal cyst growth and interstitial fibrosis","volume":"155","author":"He","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"12","key":"10.1016\/j.bcp.2024.116200_b0120","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1681\/ASN.2006030295","article-title":"Early embryonic renal tubules of wild-type and polycystic kidney disease kidneys respond to cAMP stimulation with cystic fibrosis transmembrane conductance regulator\/Na(+), K(+),2Cl(-) Co-transporter-dependent cystic dilation","volume":"17","author":"Magenheimer","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.bcp.2024.116200_b0125","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1681\/ASN.2015010047","article-title":"Phosphodiesterase Isoform Regulation of Cell Proliferation and Fluid Secretion in Autosomal Dominant Polycystic Kidney Disease","volume":"27","author":"Pinto","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.bcp.2024.116200_b0130","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.bbadis.2011.06.012","article-title":"Fibrosis and progression of autosomal dominant polycystic kidney disease (ADPKD)","volume":"1812","author":"Norman","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcp.2024.116200_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2019.109468","article-title":"The PI3K\/Akt\/mTOR pathway in polycystic kidney disease: A complex interaction with polycystins and primary cilium","volume":"66","author":"Margaria","year":"2020","journal-title":"Cell. Signal."},{"issue":"9","key":"10.1016\/j.bcp.2024.116200_b0140","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nrneph.2015.46","article-title":"The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease","volume":"11","author":"Seeger-Nukpezah","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"issue":"2","key":"10.1016\/j.bcp.2024.116200_b0145","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0272-6386(12)80507-5","article-title":"Polycystic kidney disease: neoplasia in disguise","volume":"15","author":"Grantham","year":"1990","journal-title":"Am. J. Kidney Dis."},{"issue":"6","key":"10.1016\/j.bcp.2024.116200_b0150","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1158\/0008-5472.CAN-09-3114","article-title":"Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT\/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model","volume":"70","author":"Efferson","year":"2010","journal-title":"Cancer Res."},{"issue":"33","key":"10.1016\/j.bcp.2024.116200_b0155","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1038\/s41388-018-0251-y","article-title":"Notch-1-PTEN-ERK1\/2 signaling axis promotes HER2+ breast cancer cell proliferation and stem cell survival","volume":"37","author":"Baker","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2024.116200_b0160","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1476-4598-10-138","article-title":"Targeting notch pathway enhances rapamycin antitumor activity in pancreas cancers through PTEN phosphorylation","volume":"10","author":"Vo","year":"2011","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bcp.2024.116200_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.156013","article-title":"Elevated Notch-1 expression promotes the lymph node metastasis of gastric cancer and the Notch-1-PTEN-ERK1\/2 signalling axis promotes the progression of gastric cancer","volume":"159","author":"Ma","year":"2022","journal-title":"Cytokine"},{"issue":"1\u20132","key":"10.1016\/j.bcp.2024.116200_b0170","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0925-4773(01)00373-2","article-title":"The origin of the ankyrin repeat region in Notch intracellular domains is critical for regulation of HES promoter activity","volume":"104","author":"Beatus","year":"2001","journal-title":"Mech. Dev."},{"issue":"1","key":"10.1016\/j.bcp.2024.116200_b0175","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.kint.2018.01.031","article-title":"Notch3 orchestrates epithelial and inflammatory responses to promote acute kidney injury","volume":"94","author":"Kavvadas","year":"2018","journal-title":"Kidney Int."},{"key":"10.1016\/j.bcp.2024.116200_b0180","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cellsig.2018.08.002","article-title":"The TGFbeta-ERK pathway contributes to Notch3 upregulation in the renal tubular epithelial cells of patients with obstructive nephropathy","volume":"51","author":"Huang","year":"2018","journal-title":"Cell. Signal."},{"issue":"3","key":"10.1016\/j.bcp.2024.116200_b0185","article-title":"Ubiquitination\/de-ubiquitination: A promising therapeutic target for PTEN reactivation in cancer","volume":"1877","author":"Wang","year":"2022","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.bcp.2024.116200_b0190","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc2842","article-title":"Phosphoinositide signalling in cancer: beyond PI3K and PTEN","volume":"10","author":"Bunney","year":"2010","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.bcp.2024.116200_b0195","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.7150\/thno.48679","article-title":"Histone demethylase JMJD3 protects against renal fibrosis by suppressing TGFbeta and Notch signaling and preserving PTEN expression","volume":"11","author":"Yu","year":"2021","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.bcp.2024.116200_b0200","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/s41419-021-03735-3","article-title":"Notch3 inhibits cell proliferation and tumorigenesis and predicts better prognosis in breast cancer through transactivating PTEN","volume":"12","author":"Zhang","year":"2021","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.bcp.2024.116200_b0205","doi-asserted-by":"crossref","first-page":"e1011165","DOI":"10.1371\/journal.ppat.1011165","article-title":"Berberine governs NOTCH3\/AKT signaling to enrich lung-resident memory T cells during tuberculosis","volume":"19","author":"Pahuja","year":"2023","journal-title":"PLoS Pathog."},{"issue":"12","key":"10.1016\/j.bcp.2024.116200_b0210","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s12033-022-00476-2","article-title":"Hes1 Controls Proliferation and Apoptosis in Chronic Lymphoblastic Leukemia Cells by Modulating PTEN Expression","volume":"64","author":"Zhang","year":"2022","journal-title":"Mol. Biotechnol."},{"issue":"10","key":"10.1016\/j.bcp.2024.116200_b0215","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/nm1636","article-title":"Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia","volume":"13","author":"Palomero","year":"2007","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.bcp.2024.116200_b0220","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","article-title":"The PI3K Pathway in Human Disease","volume":"170","author":"Fruman","year":"2017","journal-title":"Cell"},{"issue":"10174","key":"10.1016\/j.bcp.2024.116200_b0225","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(18)32782-X","article-title":"Autosomal dominant polycystic kidney disease","volume":"393","author":"Cornec-Le","year":"2019","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.bcp.2024.116200_b0230","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.molmed.2011.06.003","article-title":"mTOR signaling in polycystic kidney disease","volume":"17","author":"Ibraghimov-Beskrovnaya","year":"2011","journal-title":"Trends Mol. Med."},{"issue":"7","key":"10.1016\/j.bcp.2024.116200_b0235","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.2215\/CJN.01360210","article-title":"Prospects for mTOR inhibitor use in patients with polycystic kidney disease and hamartomatous diseases","volume":"5","author":"Torres","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"11","key":"10.1016\/j.bcp.2024.116200_b0240","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1073\/pnas.96.11.6199","article-title":"PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt\/protein kinase B signaling pathway","volume":"96","author":"Sun","year":"1999","journal-title":"PNAS"},{"issue":"12","key":"10.1016\/j.bcp.2024.116200_b0245","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1038\/emboj.2008.96","article-title":"pVHL and PTEN tumour suppressor proteins cooperatively suppress kidney cyst formation","volume":"27","author":"Frew","year":"2008","journal-title":"EMBO J."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224001837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224001837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:19:21Z","timestamp":1762096761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295224001837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":49,"alternative-id":["S0006295224001837"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116200","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Notch3 as a novel therapeutic target for the treatment of ADPKD by regulating cell proliferation and renal cyst development","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116200","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116200"}}